Find out how our comprehensive hematology test menu aids in diagnosis and treatment across a wide range of complex pediatric hematologic disorders.
Collaboration Paves the Way for Rapid Discovery in Autoimmune Neurology - Insights
Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.
Adapting to Fast-Paced Studying - Insights
Reilly Hannon, a student in the Mayo Clinic Medical Laboratory Science program, discusses valuable study techniques she has learned.
Learn about our world-renowned pediatric endocrinologists and genetic counselors, who are available to review results and consult on treatment plans.
Monthly updates to current procedural terminology (CPT) codes and logical observation identifiers names and codes (LOINC).
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...
Commercial laboratories - Insights
Mayo Clinic Laboratories is a one stop laboratory solution for commercial laboratories, offering the industry’s most comprehensive test menu, 24/7 customer service support and streamlined logistics to help clients meet their business goals.
Mayo Clinic Start-up Earns World Economic Forum Award - Insights
Mayo Clinic startup company Vineti developed first-of-its-kind software package tracking for cell therapies. Vineti’s groundbreaking product captured a World Economic Forum Technology Pioneer Award in the field of health.
Week in Review: May 6 - Insights
Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision
Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D., explain how Mayo Clinic Laboratories' unique risankizumab panel measures levels of both that drug and its antibodies in patients' blood. The results can better guide the management of...